An ED-based risk stratification tool should: |
11 Identify serious outcomes that are recognized during the ED evaluation |
12 Identify serious outcomes occurring within 7 days after the ED visit |
13 Identify serious outcomes occurring 7–30 days after the ED visit |
Clinically important serious outcomes that should be predicted by a risk stratification tool include: |
Mortality: |
14 Cardiac death |
15 Syncope-related death |
Arrhythmias |
16 Ventricular fibrillation |
17 Ventricular tachycardia > 30 seconds |
18 Symptomatic ventricular tachycardia < 30 seconds |
19 Sick sinus syndrome with alternating sinus bradycardia and tachycardia |
20 Sinus pause > 3 seconds |
21 Mobitz type II atrioventricular heart block |
22 Complete heart block |
23 Pacemaker or implantable cardioverter-defibrillator malfunction with cardiac pauses. |
Structural/ Ischemic Heart Disease |
24 Aortic stenosis with valve area ≤ 1 cm2
|
25 Hypertrophic cardiomyopathy with outflow tract obstruction |
26 Left atrial myxoma or thrombus with outflow tract obstruction |
27 Myocardial infarction |
Other Outcomes |
28 Pulmonary embolus |
29 Aortic dissection |
30 Internal hemorrhage or anemia requiring transfusion |
31 Recurrent syncope or fall resulting in major traumatic injury (trauma that requires admission or procedural/surgical intervention) |
32 Permanent pacemaker or defibrillator placement |
33 Cardiopulmonary resuscitation |